Opaleye Management’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-100,000
| Closed | -$469K | – | 55 |
|
|
2019
Q2 | $469K | Buy |
+100,000
| New | +$469K | 0.14% | 41 |
|
|
2019
Q1 | – | Sell |
-250,000
| Closed | -$777K | – | 58 |
|
|
2018
Q4 | $777K | Hold |
250,000
| – | – | 0.29% | 41 |
|
|
2018
Q3 | $1.82M | Sell |
250,000
-60,000
| -19% | -$436K | 0.46% | 39 |
|
|
2018
Q2 | $1.33M | Sell |
310,000
-16,000
| -5% | -$68.8K | 0.35% | 33 |
|
|
2018
Q1 | $1.76M | Buy |
326,000
+143,500
| +79% | +$775K | 0.5% | 32 |
|
|
2017
Q4 | $1.21M | Buy |
+182,500
| New | +$1.21M | 0.39% | 31 |
|